Literature DB >> 11487004

Von Willebrand factor propeptide in vascular disorders.

J A van Mourik1, T Romani de Wit.   

Abstract

Von Willebrand factor (VWF) is a multifunctional plasma protein that plays a prominent role in haemostasis. In endothelial cells, processing of its precursor pro-VWF results in the formation of two large polypeptides, mature VWF and a propeptide. These proteins are co-secreted on an equimolar basis but are cleared from the circulation at different rates. VWF levels are frequently elevated in response to vascular disorders. Similarly, propeptide levels are increased under these conditions, although primarily in fulminant vascular disease, such as thrombotic thrombocytopenic purpura and septicemia. In chronic vascular disease, e.g. diabetes or peripheral vascular disease, propeptide levels are much less elevated. The differential response of VWF and propeptide levels to vascular disease could provide a means to assess the extent and time course of endothelial cell activation. After secretion, the propeptide may play a role in modulating cellular adhesion processes. Thus, enhanced propeptide secretion seems not to be of merely diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487004

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Evaluating Immunopathogenic Biomarkers During Severe Malaria Illness as Modifiers of the Neuropsychologic Benefits of Computer Cognitive Games Rehabilitation in Ugandan Children.

Authors:  Michael J Boivin; Alla Sikorskii; Noeline Nakasujja; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Robert O Opoka; Bruno Giordani
Journal:  Pediatr Infect Dis J       Date:  2019-08       Impact factor: 2.129

2.  Markers of vascular perturbation correlate with airway structural change in asthma.

Authors:  Mats W Johansson; Stanley J Kruger; Mark L Schiebler; Michael D Evans; Ronald L Sorkness; Loren C Denlinger; William W Busse; Nizar N Jarjour; Robert R Montgomery; Deane F Mosher; Sean B Fain
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

Review 3.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

4.  Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

Authors:  S Albánez; K Ogiwara; A Michels; W Hopman; J Grabell; P James; D Lillicrap
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824

5.  Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.

Authors:  Alan Bulava; Ludek Slavík; Martin Fiala; Petr Heinc; Marcela Skvarilova; Jan Lukl; Vera Krcová; Karel Indrák
Journal:  J Interv Card Electrophysiol       Date:  2004-06       Impact factor: 1.900

6.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

7.  Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors:  David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal:  Toxicol Pathol       Date:  2014-02-04       Impact factor: 1.902

8.  Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria.

Authors:  Happy T Phiri; Daniel J Bridges; Simon J Glover; Jan A van Mourik; Bas de Laat; Bridon M'baya; Terrie E Taylor; Karl B Seydel; Malcolm E Molyneux; E Brian Faragher; Alister G Craig; James E G Bunn
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

9.  Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells.

Authors:  Muriel Meiring; W Allers; E Le Roux
Journal:  Int J Med Sci       Date:  2016-09-20       Impact factor: 3.738

10.  Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases.

Authors:  Noritaka Yada; Kiyomi Yoshimoto; Hiromasa Kawashima; Ryo Yoneima; Nobushiro Nishimura; Yoshiaki Tai; Emiko Tsushima; Makiko Miyamoto; Shiro Ono; Masanori Matsumoto; Takashi Fujimoto; Kenji Nishio
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.